Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innospec (IOSP) Shares Outstanding (Weighted Average) (2016 - 2025)

Innospec (IOSP) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $24.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.21% to $24.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.9 million through Dec 2025, changed 0.21% year-over-year, with the annual reading at $24.9 million for FY2025, 0.21% changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $24.9 million in Q4 2025 for Innospec, roughly flat from $24.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $25.0 million in Q1 2025 to a low of $24.6 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $24.8 million across 5 years, with a median of $24.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.77% in 2022 and later fell 0.37% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $24.6 million in 2021, then increased by 0.57% to $24.8 million in 2022, then rose by 0.26% to $24.9 million in 2023, then grew by 0.33% to $24.9 million in 2024, then decreased by 0.21% to $24.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IOSP at $24.9 million in Q4 2025, $24.8 million in Q3 2025, and $25.0 million in Q2 2025.